Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
UDENYCA Logo
UDENYCA Growth Score
76
CB Rank
2295547
Heat Score
6
UDENYCA is a prescription medication that offers patients and healthcare professionals flexibility, control, and convenience.
Acquired by
Intas Pharmaceuticals Logo
Intas Pharmaceuticals
Private Redwood City, California, United States udenyca.com
Health Care
Medical
Overview

UDENYCA
Growth Score
76
Heat Score
6

Growth Score76
-9 pts
in past quarter
Heat Score 6
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About UDENYCA

CB Rank
2295547
UDENYCA is a prescription medication that offers patients and healthcare professionals flexibility, control, and convenience.
Acquired by
Intas Pharmaceuticals Logo
Intas Pharmaceuticals
Private Redwood City, California, United States udenyca.com
Health Care
Medical

Details

Sub-Organization of 
Coherus Biosciences Logo
Coherus Biosciences
Operating Status Active
Company Type For Profit
About the Company
UDENYCA is a prescription medication that offers patients and healthcare professionals flexibility, control, and convenience.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

UDENYCA
A prescription medication used to reduce infection risk by increasing white blood cell count in patients with certain cancers undergoing chemotherapy.
UDENYCA Prefilled Syringe
A single-dose prefilled syringe containing 6 mg/0.6 mL of UDENYCA for manual injection.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

M&A Details

UDENYCA was acquired by Intas Pharmaceuticals for
obfuscation
on
obfuscation
. This deal was done in Cash.
Transaction Name 
UDENYCA acquired by Intas Pharmaceuticals Logo
UDENYCA acquired by Intas Pharmaceuticals
Acquired by 
Intas Pharmaceuticals Logo
Intas Pharmaceuticals
Announced Date 
obfuscation
Price 
obfuscation
Market Intelligence
People
View Profiles & Contacts
News
Technology
View Tech Report

Monthly Web Visits

24,544
272.67%
 in past month

IT Spend

$5.6MThis year, UDENYCA is projected to spend $5.6M on IT, according to Aberdeen.

Active Website Tech Count

28UDENYCA is actively using 28 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.
Sub-Organizations
Frequently Asked Questions

Where is UDENYCA's headquarters? UDENYCA is located in Redwood City, California, United States.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d4095e5 1)
|